Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adi...

Full description

Bibliographic Details
Main Authors: Hernán Paublini, Angel Arturo López González, Carla Busquets-Cortés, Pilar Tomas-Gil, Pere Riutord-Sbert, José Ignacio Ramírez-Manent
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/9/2105
_version_ 1797602022718963712
author Hernán Paublini
Angel Arturo López González
Carla Busquets-Cortés
Pilar Tomas-Gil
Pere Riutord-Sbert
José Ignacio Ramírez-Manent
author_facet Hernán Paublini
Angel Arturo López González
Carla Busquets-Cortés
Pilar Tomas-Gil
Pere Riutord-Sbert
José Ignacio Ramírez-Manent
author_sort Hernán Paublini
collection DOAJ
description Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.
first_indexed 2024-03-11T04:10:19Z
format Article
id doaj.art-a93a68122e594616a1202e069fc4f4c8
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T04:10:19Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-a93a68122e594616a1202e069fc4f4c82023-11-17T23:29:11ZengMDPI AGNutrients2072-66432023-04-01159210510.3390/nu15092105Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin ResistanceHernán Paublini0Angel Arturo López González1Carla Busquets-Cortés2Pilar Tomas-Gil3Pere Riutord-Sbert4José Ignacio Ramírez-Manent5Research Group Adema Salud IUNICS, 07003 Palma, SpainResearch Group Adema Salud IUNICS, 07003 Palma, SpainResearch Group Adema Salud IUNICS, 07003 Palma, SpainResearch Group Adema Salud IUNICS, 07003 Palma, SpainResearch Group Adema Salud IUNICS, 07003 Palma, SpainResearch Group Adema Salud IUNICS, 07003 Palma, SpainBackground: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.https://www.mdpi.com/2072-6643/15/9/2105atherogenic dyslipidaemialipid triadinsulin resistanceatherogenic risk
spellingShingle Hernán Paublini
Angel Arturo López González
Carla Busquets-Cortés
Pilar Tomas-Gil
Pere Riutord-Sbert
José Ignacio Ramírez-Manent
Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
Nutrients
atherogenic dyslipidaemia
lipid triad
insulin resistance
atherogenic risk
title Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_full Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_fullStr Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_full_unstemmed Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_short Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_sort relationship between atherogenic dyslipidaemia and lipid triad and scales that assess insulin resistance
topic atherogenic dyslipidaemia
lipid triad
insulin resistance
atherogenic risk
url https://www.mdpi.com/2072-6643/15/9/2105
work_keys_str_mv AT hernanpaublini relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT angelarturolopezgonzalez relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT carlabusquetscortes relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT pilartomasgil relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT pereriutordsbert relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT joseignacioramirezmanent relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance